DOPPS Practice Monitor: Emerging trends and new research

Researchers from the Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor (DPM) has been updated with data current through October 2016, based on a national sample of US dialysis facilities, at www.DOPPS.org/DPM.

Noteworthy trends include:

  • The DOPPS Practice Monitor has noted a substantial trend in the types of ESA prescribed to US hemodialysis (HD) patients. Mircera (pegylated epoetin beta) use has quickly risen among large dialysis organization (LDO) facilities. As of October 2016, Mircera is estimated to be used by 35% of patients overall (from 0% as recently as March 2015). Distribution of hemoglobin levels have been generally stable since 2013, with mean 10.8 g/dl. Click to view graphics showing ESA use by type.

About the DPM: The DPM is based on a sample of over 11,000 patients in more than 200 US hemodialysis facilities. Research papers describing DPM methods, key recent findings and analysis, and commentary have been published. To learn more, please visit DOPPS.org/DPM.

Would you like to receive more updates about the DPM? Sign up here.